FMR1 gene expression in olfactory neuroblasts from two males with fragile X syndrome

American Journal of Medical Genetics

Volumn 82, Issue 1, 1999, Pages 25-30

  Abrams, Michael T ^a,b   Kaufmann, Walter E ^a   Rousseau, François ^c   Oostra, Ben A ^d   Wolozin, Benjamin ^e   Taylor, Christopher V ^a   Lishaa, Nancy ^a,b   Morel, Marie Lou ^c   Hoogeveen, Andre ^d   Reiss, Allan L ^f  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

^c LAVAL UNIVERSITY   (Canada)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^e LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

FMR1; FMRP; Fragile X; Leukocytes; Olfactory neuroblasts

Indexed keywords

ADULT; ARTICLE; BRAIN DEVELOPMENT; CASE REPORT; DIZYGOTIC TWINS; FRAGILE X SYNDROME; GENE EXPRESSION; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; NEUROBLAST; OLFACTORY NERVE; PRIORITY JOURNAL;

ADULT; CELLS, CULTURED; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENE EXPRESSION; HUMANS; INTELLIGENCE TESTS; MALE; NERVE TISSUE PROTEINS; NEURONS; OLFACTORY BULB; RESTRICTION MAPPING; RNA-BINDING PROTEINS; TWINS;

MAMMALIA;

EID: 0032920310     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19990101)82:1<25::AID-AJMG5>3.0.CO;2-Y     Document Type: Article

References (53)

1. Abrams MT, Reiss AL. 1995. The neurobiology of Fragile X syndrome. Ment Retard Dev Dis Res Rev 1:269-275.
2. Abrams MT, Reiss AL, Freund LS, Baumgardner TL, Chase GA, Denckla MB. 1994. Molecular-neurobehavioral associations in females with the fragile X full mutation. Am J Med Genet 51:317-327.
3. Bailey D, Nelson D. 1995. The nature and consequences of Fragile X syndrome. Ment Retard Dev Dis Res Rev 1:238-243.
4. Camara C, Harding J. 1984. Thymidine incorporation in the olfactory epithelium of mice: Early exponential response induced by olfactory neurectomy. Brain Res 308:63-68.
5. Cohen I, Nolin S, Sudhalter V, Ding X-H, Dobkin C. Brown T. 1996. Mosaicism for the fmr1 gene influences adaptive skills development in fragile X-affected males. Am J Med Genet 64:356-369.
6. de Graaff E, Rouillard P, Willems PJ, Smits AP, Rousseau F, Oostra BA. 1995a. Hotspot for deletions in the CGG repeat region of FMR1 in fragile X patients. Hum Mol Genet 4:45-49.
7. de Graaff E, Willemsen R, Zhong N, de Die-Smulders CEM, Brown WT, Freling G, Oostra B. 1995b. Instability of the CGG repeat and expression of the FMR1 protein in a male fragile X patient with a lung tumor. Am J Hum Genet 75:609-618.
8. de Vries BBA, Wiegers AM, Smits APT, Mohkamsing S, Duivenvoorden HJ, Fryns J-P, Curfs LMG, Halley DJJ, Oostra BA, van den Ouweland AMW, Niermeijer MF. 1996. Mental status of females with an FMR1 gene full mutation. Am J Hum Genet 58:1025-1032.
9. Devys D, Biancalana V, Rousseau F, Boué J, Mandel JL, Oberlé I. 1992. Analysis of full fragile X mutations in fetal tissues and monozygotic twins indicate that abnormal methylation and somatic heterogeneity are established early in development. Am J Med Genet 43:208-216.
10. Devys D, Lutz Y, Rouyer N, Bellocq J-P, Mandel J-L. 1993. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet 4:335-340.
11. Dodd J, Castellucci V. 1991. Smell and taste: the chemical senses. In: Kandel ER, Schwartz JH, Jessell TM, editors: Principles of neural science. New York: Elsevier Science Publishing.
12. Feng Y, Gutekunst C-A, Eberhart DE, Yi H, Warren ST, Hersch SM. 1997. Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J Neurosci 17:1539-1547.
13. Feng Y, Lakkis L, Devys D, Warren ST. 1995. Quantitative comparison of FMR1 gene expression in normal and premutation alleles. Am J Hum Genet 56:106-113.
14. Graziadei PP, Monti Graziadei AG. 1983. Regeneration in the olfactory system of vertebrates. Am J Otolaryngol 4:228-233.
15. Hagerman R. 1995. Molecular and clinical correlations in Fragile X syndrome. Ment Retard Dev Disab Res Rev 1:276-280.
16. Hagerman R, Staley L, O'Conner R, Lugenbeel K, Nelson D, McLean S, Taylor A. 1996. Learning-disabled males with a fragile X CGG expansion in the upper premutation size range. Pediatrics 97:122-126.
17. Hagerman RJ. 1996. Physical and behavioral phenotype. In: Hagerman RJ, Cronister AC, editors: Fragile X syndrome. Baltimore: Johns Hopkins University Press, p 3-68.
18. Hansen RS, Gartler SM, Scott CR, Chen S-H, Laird CD. 1992. Methylation analysis of CGG sites in the CpG island of the human FMR1 gene. Hum Mol Genet 1:571-578.
19. Hirst M, Grewal P, Flannery A, Slatter R, Maher E, Barton D, Fryns JP, Davies K. 1995. Two new cases of FMR1 deletion associated with mental impairment. Am J Hum Genet 56:67-74.
20. Johnson G, Basaric-Keys J, Ghanbari H, Lebovics R, Lesch K, Merril C, Sunderland T, Wolozin B. 1994. Protein alterations in olfactory neuroblasts from Alzheimer donors. Neurobiol Aging 15:675-680.
21. Kaufmann WE, Worley PF, Pegg J, Bremer M, Isakson P. 1996. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc Natl Acad Sci USA 93: 2317-2321.
22. Khandjian E, Fortin A, Thibodeau A, Tremblay S, Cote F, Devys D, Mandel JL, Rousseau F. 1995. A heterogeneous set of FMR1 proteins is widely distributed in mouse tissues and is modulated in cell culture. Hum Mol Gen 4:783-789.
23. Linman J. 1975. Hematology: physiologic, pathophysiologic, and clinical principles. New York: Macmillan Publishing Company.
24. Loesch DZ, Hay DA, Mulley J. 1994. Transmitting males and carrier females in fragile X-revisited. Am J Med Genet 51:392-399.
25. Lovell M, Jafek B, Moran D, Rowley J. 1982. Biopsy of human olfactory mucosa. Arch Otolaryngol 108:247-249.
26. Maddalena A, Yadvish KN, Spence WC, Howard-Peebles PN. 1996. A fragile X mosaic male with a cryptic full mutation detected in epithelium but not in blood. Am J Med Genet 64:309-312.
27. Malter HE, Iber JC, Willemsen R, de Graaff E, Tarlton JC, Leisti J, Warren ST, Oostra BA. 1997. Characterization of the full fragile X syndrome mutation in fetal gametes. Nat Genet 15:165-169.
28. Mazzocco MMM, Freund LS, Baumgardner TL, Forman L, Reiss AL. 1995. Neuropsychological and psychosocial effects of the FMR-1 full mutation: Case report of monozygotic twins discordant for the Fragile X syndrome. Neuropsychology 9:470-480.
29. Mazzocco MM, Kates WR, Baumgardner TL, Freund LS, Reiss AL. 1997. Autistic behavior among girls with Fragile X syndrome. J Autism Dev Disord 27:415-435.
30. Meijer H, de Graaff E, Merckx DM, Jongbloed RJ, de Die-Smulders CE, Engelen JJ, Fryns JP, Curfs PM, Oostra BA. 1994. A deletion of 1.6 kb proximal to the CGG repeat of the FMR1 gene causes the clinical phenotype of the fragile X syndrome. Hum Mol Genet 3:615-620.
31. Nolin SL, Glicksman A, Houck GJ, Brown WT, Dobkin CS. 1994. Mosaicism in fragile X affected males. Am J Med Genet 51:509-512.
32. Oberlé I, Rousseau F, Heitz D, Kretz C, Devys D, Hanauer A, Boue J, Bertheas MF, Mandel JL. 1991. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252: 1097-1102.
33. Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT, Nelson DL. 1991. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66:817-822.
34. Reiss AL, Abrams MT, Greenlaw R, Freund L, Denckla MB. 1995a. Neurodevelopmental effects of the FMR-1 full mutation in humans. Nat Med 1:159-167.
35. Reiss AL, Aylward E, Freund LS, Joshi PK, Bryan RN. 1991. Neuroanatomy of fragile X syndrome: The posterior fossa. Ann Neurol 29:26-32.
36. Reiss AL, Freund LF, Baumgardner TL, Abrams MT, Denckla MB. 1995b. Contribution of the FMR1 gene mutation to human intellectual dysfunction. Nat Genet 11:331-334.
37. Reiss AL, Freund L. 1992. Behavioral phenotype of fragile X syndrome: DSM-III-R autistic behavior in male children. Am J Med Genet 43:35-46.
38. Reiss AL, Lee J, Freund L. 1994. Neuroanatomy of fragile X syndrome: The temporal lobe. Neurology 44:1317-1324.
39. Reyniers E, Vits L, De Boulle K, Van Roy B, Van Velzen D, de Graaff E, Verkerk AJ, Jorens HZ, Darby JK, Oostra B. 1993. The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm. Nat Genet 4:143-146.
40. Rousseau F, Heitz D, Biancalana V, Blumenfeld S, Kretz C, Boue J, Tommerup N, Van Der Hagen C, DeLozier-Blanchet C, Croquette MF, Gilgenkrantz S, Jalbert P, Voelckel MA, Oberlé I, Mandel JL. 1991a. Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N Engl J Med 325:1673-1681.
41. Rousseau F, Heitz D, Oberlé I, Mandel JL. 1991b. Selection in blood cells from female carriers of the fragile X syndrome: Inverse correlation between age and proportion of active X chromosomes carrying the full mutation. J Med Genet 28:830-836.
42. Rousseau F, Heitz D, Tarleton J, MacPherson J, Malmgren H, Dahl N, Barnicoat A, Mathew C, Mornet E, Tejada I, Maddalena A, Spiegel R, Schinzel A, Marcos JAG, Schwartz C, Mandel JL. 1994. A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: The first 2,253 cases. Am J Hum Genet 55:225-237.
43. Sutcliffe JS, Nelson DL, Zhang F, Pieretti M, Caskey CT, Saxe D, Warren ST. 1992. DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet 1:397-400.
44. Talamo BR, Rudel R, Kosik KS, Lee VM, Neff S, Adelman L, Kauer JS. 1989. Pathological changes in olfactory neurons in patients with Alzheimer's disease. Nature 337:736-739.
45. Taylor AK, Tassone F, Dyer PN, Hagerman RJ. 1996. Studies of the FMR1 mutation in multiple tissues: dramatic differences between tissues of a high functioning male but not of a typical fragile X male. Am J Hum Genet 59:A288.
46. Taylor AK, Safanda JF, Fall MZ, Quince C, Lang KA, Hull CE, Carpenter I, Staley LW, Hagerman RJ. 1994. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome. JAMA 271:507-514.
47. Verheij C, Bakker CE, de Graaff E, Keulemans J, Willemsen R, Verkerk AJ, Galjaard H, Reuser AJ, Hoogeveen AT, Oostra BA. 1993. Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature 363:722-724.
48. Verheij C, de Graaff E, Bakker C, Willemsen R, Willems P, Meijer N, Galjaard H, Reuser A, Oostra B, Hoogeveen A. 1995. Characterization of FMR1 proteins isolated from different tissues. Hum Mol Genet 4: 895-901.
49. Wöhrle D, Hennig I, Vogel W, Steinbach P. 1993. Mitotic stability of fragile X mutations in differentiated cells indicates early post-conceptional trinucleotide repeat expansion. Nat Genet 4:140-142.
50. Wöhrle D, Hirst MC, Kennerknecht I, Davies KE, Steinbach P. 1992. Genotype mosaicism in fragile X fetal tissues. Hum Genet 89:114-116.
51. Wöhrle D, Kennerknecht I, Wolf M, Enders H, Schwemmle S, Steinbach P. 1995. Heterogeneity of DM kinase repeat expansion in different fetal tissues and further expansion during cell proliferation in vitro: evidence for a causal involvement of methyl-directed DNA mismatch repair in triplet repeat stability. Hum Mol Genet 4:1147-1153.
52. Wolozin B, Sunderland T, Zheng BB, Resau J, Dufy B, Barker J, Swerdlow R, Coon H. 1992. Continuous culture of neuronal cells from adult human olfactory epithelium. J Mol Neurosci 3:137-146.
53. Wolozin BL, Lesch KP, Lebovics RS, Sunderland T. 1993. Olfactory neuroblasts from Alzheimer donors: Studies on APP processing and cell regulation. Biol Psychiatry 34:824-838.